GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care
April 28 2022 - 10:00AM
Business Wire
Providing excellent care inside and outside of the traditional
hospital is the new normal for patients, clinicians, and payers
seeking more choices without compromising excellent outcomes.
Today, GE Healthcare and Medtronic announce a collaboration focused
on the unique needs and demand for care at Ambulatory Surgery
Centers (ASCs) and Office Based Labs (OBLs). Under this new
collaboration, customers can access extensive product portfolios,
financial solutions, and exceptional service.
The COVID-19 pandemic accelerated the movement of procedures
into the outpatient environment while also driving disease rates
higher, resulting in procedure growth in facilities outside
traditional hospitals, and this growth trend is expected to
continue for years to come.1 Also, since CMS approved payments for
certain cardiovascular procedures in 2020, fixed c-arm imaging
systems have been used more and more frequently in ASCs and OBLs
for cardiac and peripheral vascular procedures.2
“GE Healthcare Interventional Imaging solutions are built to
help our customers deliver care at a higher level for patients.
With a predicted increase in outpatient cardiology and peripheral
vascular procedures over the coming years, industry leaders like GE
Healthcare need to understand and meet the unique needs of ASCs and
OBLs,” said Jim Rapp, Vice President of Interventional Imaging at
GE Healthcare. “Our collaboration with Medtronic is one aspect of
our efforts to strengthen efficiency, workflow, and clinical
outcomes for ASCs and OBLs who work with GE Healthcare.”
While patient needs are increasing, there remain high costs and
complexity associated with expanding an existing ASC or building a
new one. GE Healthcare and Medtronic seek to help ASCs navigate
these challenges, bringing the best of each company to deliver
high-quality and cost-effective advanced technology, financial
solutions, and personal service. For GE Healthcare, this includes
consultative planning, construction, a comprehensive suite of
equipment (including imaging, monitoring, and ultrasound), and
exceptional service and digital solutions, including the
Edison-powered AutoRight A.I.-based interventional imaging chain,
which can help clinicians provide the right image at the right dose
automatically for each patient. For Medtronic, this means providing
an extensive portfolio of products for a diverse range of service
lines in the ASC and OBL, from cardiac rhythm to pain management,
peripheral vascular to kyphoplasty. In addition to products,
Medtronic will continue to offer the service that customers have
come to expect from their field experts as well as reimbursement
support, remote solutions, and more.
“As our customers open centers outside of the hospital, they are
looking for support beyond the devices used in medical procedures,”
said Adam King, Senior Director of U.S. Enterprise Accounts and
Ambulatory Surgery Centers at Medtronic. “From products and devices
to equipment and services, we provide a full range of technologies
and solutions. Our collaboration with GE Healthcare was formed to
better serve the growth of our ASC and OBL customers with extensive
technologies and dedicated teams who have expertise in outpatient
services and can address all aspects of this evolving sector.”
From staff workflow to patient care and more, GE Healthcare and
Medtronic experts and solutions help outpatient health center
owners and clinicians achieve their vision.
About GE Healthcare:
GE Healthcare is the $17.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications, and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 47,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improve outcomes for patients, providers,
health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights
for the latest news, or visit our website www.gehealthcare.com for
more information.
About Medtronic:
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc,
headquartered in Dublin, Ireland, is the leading global healthcare
technology company that boldly attacks the most challenging health
problems facing humanity by searching out and finding solutions.
Our Mission — to alleviate pain, restore health, and extend life —
unites a global team of 90,000+ passionate people across 150
countries. Our technologies and therapies treat 70 health
conditions and include cardiac devices, surgical robotics, insulin
pumps, surgical tools, patient monitoring systems, and more.
Powered by our diverse knowledge, insatiable curiosity, and desire
to help all those who need it, we deliver innovative technologies
that transform the lives of two people every second, every hour,
every day. Expect more from us as we empower insight-driven care,
experiences that put people first, and better outcomes for our
world. In everything we do, we are engineering the extraordinary.
For more information on Medtronic (NYSE:MDT), visit
www.Medtronic.com and follow @Medtronic on Twitter and
LinkedIn.
1Sg2 2021 Impact of Change® Forecast:
Post-Pandemic Recovery, Rising Acuity and Ambulatory Shifts. Read
more:
https://www.sg2.com/health-care-intelligence-blog/2021/06/sg2-2021-impact-of-change-forecast/
2The Rise of the Cardiology ASC – Update. Read
more: https://www.ghadvisors.net/research-reports/gha-the-rise-of-the-cardiology-asc/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220428005044/en/
Emily Davis Emily.Davis1@ge.com +1.630.779.0772
Erika Winkels Medtronic plc Public Relations +1.763.526.8478
Ryan Weispfenning Medtronic plc Investor Relations
+1.763.505.4626
General Electric (NYSE:GE)
Historical Stock Chart
From Feb 2024 to Mar 2024
General Electric (NYSE:GE)
Historical Stock Chart
From Mar 2023 to Mar 2024